Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Gerosa

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Dermatovenerologica Croatica : ADC|July 14, 2025
Erythrodermic Psoriasis: Excellent Management Avoiding HospitalizationSilvia Gerosa, Giorgia Ravaglia, Carolina Fantini, et al.
Journal of Personalized Medicine|January 27, 2026
Effectiveness of Bimekizumab in Multi-Failure Psoriatic Patients: A Retrospective, Real-World Multicenter StudyFrancesca Satolli, Giulia Rech, Silvia Gerosa, et al.
Frontiers in Oncology|October 27, 2025
SUNTEL pilot study: first school-based integration of the ugly duckling sign and a dedicated e-learning platform with peer education for melanoma preventionIgnazio Stanganelli, Serena Magi, Elisabetta Costa, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Dermatovenerologica Croatica : ADC|July 14, 2025
Erythrodermic Psoriasis: Excellent Management Avoiding HospitalizationSilvia Gerosa, Giorgia Ravaglia, Carolina Fantini, et al.
Journal of Personalized Medicine|January 27, 2026
Effectiveness of Bimekizumab in Multi-Failure Psoriatic Patients: A Retrospective, Real-World Multicenter StudyFrancesca Satolli, Giulia Rech, Silvia Gerosa, et al.
Frontiers in Oncology|October 27, 2025
SUNTEL pilot study: first school-based integration of the ugly duckling sign and a dedicated e-learning platform with peer education for melanoma preventionIgnazio Stanganelli, Serena Magi, Elisabetta Costa, et al.
Clinical and Experimental Dermatology|June 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective studyFrancesca Satolli, Silvia Gerosa, Martina Burlando, et al.
Pageof 1